Odronextamab

Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)

Regeneron PharmaceuticalsPhase 3

—

Rating in progress

Odronextamab in Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active